相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Tumor microenvironment targeted nanotherapeutics for cancer therapy and diagnosis: A review
Shreya Thakkar et al.
ACTA BIOMATERIALIA (2020)
An insight of microRNAs performance in carcinogenesis and tumorigenesis; an overview of cancer therapy
Kosar Babaei et al.
LIFE SCIENCES (2020)
Cellular adaptation to hypoxia through hypoxia inducible factors and beyond
Pearl Lee et al.
NATURE REVIEWS MOLECULAR CELL BIOLOGY (2020)
Cancer associated fibroblasts as novel promising therapeutic targets in breast cancer
Sevda Salimifard et al.
PATHOLOGY RESEARCH AND PRACTICE (2020)
The dual role of tumor necrosis factor-alpha (TNF-α) in breast cancer: molecular insights and therapeutic approaches
Daniel Cruceriu et al.
CELLULAR ONCOLOGY (2020)
Chemokines and their Receptors: Multifaceted Roles in Cancer Progression and Potential Value as Cancer Prognostic Markers
Ha Thi Thu Do et al.
CANCERS (2020)
A framework for advancing our understanding of cancer-associated fibroblasts
Erik Sahai et al.
NATURE REVIEWS CANCER (2020)
Biological mechanisms linked to inflammation in cancer: Discovery of tumor microenvironment-related biomarkers and their clinical application in solid tumors
Paola Nistico et al.
INTERNATIONAL JOURNAL OF BIOLOGICAL MARKERS (2020)
Nanosoldiers: A promising strategy to combat triple negative breast cancer
Akshayya Pawar et al.
BIOMEDICINE & PHARMACOTHERAPY (2019)
Precise targeting of POLR2A as a therapeutic strategy for human triple negative breast cancer
Jiangsheng Xu et al.
NATURE NANOTECHNOLOGY (2019)
Cancer-associated fibroblasts in gastrointestinal cancer
Hiroki Kobayashi et al.
NATURE REVIEWS GASTROENTEROLOGY & HEPATOLOGY (2019)
Co-Expression of VEGF and IL-6 Family Cytokines is Associated with Decreased Survival in HER2 Negative Breast Cancer Patients: Subtype-Specific IL-6 Family Cytokine-Mediated VEGF Secretion
Ken Tawara et al.
TRANSLATIONAL ONCOLOGY (2019)
Small Peptide Ligands for Targeting EGFR in Triple Negative Breast Cancer Cells
Hanieh Hossein-Nejad-Ariani et al.
SCIENTIFIC REPORTS (2019)
The IL-17 Family of Cytokines in Health and Disease
Mandy J. McGeachy et al.
IMMUNITY (2019)
Activated Fibroblast Program Orchestrates Tumor Initiation and Progression; Molecular Mechanisms and the Associated Therapeutic Strategies
Go J. Yoshida et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2019)
STAT3 as a potential therapeutic target in triple negative breast cancer: a systematic review
Jiang-Jiang Qin et al.
JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH (2019)
The effects and the mechanisms of autophagy on the cancer-associated fibroblasts in cancer
Yuanliang Yan et al.
JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH (2019)
An overview of active and passive targeting strategies to improve the nanocarriers efficiency to tumour sites
Mohamed F. Attia et al.
JOURNAL OF PHARMACY AND PHARMACOLOGY (2019)
In Vivo Evaluation of Dual-Targeted Nanoparticles Encapsulating Paclitaxel and Everolimus
Loujin Houdaihed et al.
CANCERS (2019)
Aptamer functionalized curcumin-loaded human serum albumin (HSA) nanoparticles for targeted delivery to HER-2 positive breast cancer cells
Tayebeh Saleh et al.
INTERNATIONAL JOURNAL OF BIOLOGICAL MACROMOLECULES (2019)
Lipoamino acid-based cerasomes for doxorubicin delivery: Preparation and in vitro evaluation
A. Gileva et al.
MATERIALS SCIENCE AND ENGINEERING C-MATERIALS FOR BIOLOGICAL APPLICATIONS (2019)
Improving breast cancer therapy using doxorubicin loaded solid lipid nanoparticles: Synthesis of a novel arginine-glycine-aspartic tripeptide conjugated, pH sensitive lipid and evaluation of the nanomedicine in vitro and in vivo
Gang Zheng et al.
BIOMEDICINE & PHARMACOTHERAPY (2019)
Rationally designed hyaluronic acid-based nano-complexes for pentamidine delivery
Flavia Carton et al.
INTERNATIONAL JOURNAL OF PHARMACEUTICS (2019)
Cancer-associated fibroblasts: an emerging target of anti-cancer immunotherapy
Tongyan Liu et al.
JOURNAL OF HEMATOLOGY & ONCOLOGY (2019)
TRAF2 Controls Death Receptor-Induced Caspase-8 Processing and Facilitates Proinflammatory Signaling
Jennifer Kreckel et al.
FRONTIERS IN IMMUNOLOGY (2019)
Inflammatory pathway interactions and cancer multidrug resistance regulation
Seyed Abbas Mirzaei et al.
LIFE SCIENCES (2019)
Theranostic nanoparticles with tumor-specific enzyme-triggered size reduction and drug release to perform photothermal therapy for breast cancer treatment
Rui Liu et al.
ACTA PHARMACEUTICA SINICA B (2019)
Nitroimidazole derivative incorporated liposomes for hypoxia-triggered drug delivery and enhanced therapeutic efficacy in patient-derived tumor xenografts
Yi Li et al.
ACTA BIOMATERIALIA (2019)
Targeting L-Lactate Metabolism to Overcome Resistance to Immune Therapy of Melanoma and Other Tumor Entities
Rene G. Feichtinger et al.
JOURNAL OF ONCOLOGY (2019)
Inflammation, immunosuppressive microenvironment and breast cancer: opportunities for cancer prevention and therapy
Sachin Kumar Deshmukh et al.
ANNALS OF TRANSLATIONAL MEDICINE (2019)
Folate receptor-targeted liposomal nanocomplex for effective synergistic photothermal-chemotherapy of breast cancer in vivo
Van Du Nguyen et al.
COLLOIDS AND SURFACES B-BIOINTERFACES (2019)
Attracting Attention: Discovery of IL-8/CXCL8 and the Birth of the Chemokine Field
Bethany B. Moore et al.
JOURNAL OF IMMUNOLOGY (2019)
Breast Cancer Metastasis: Are Cytokines Important Players During Its Development and Progression?
Lucia Angelica Mendez-Garcia et al.
JOURNAL OF INTERFERON AND CYTOKINE RESEARCH (2019)
The Interferon-Gamma Paradox in Cancer
M. Raza Zaidi
JOURNAL OF INTERFERON AND CYTOKINE RESEARCH (2019)
Hypoxia: Overview on Hypoxia-Mediated Mechanisms with a Focus on the Role of HIF Genes
Alexandru Andrei Tirpe et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2019)
Myeloid-Derived Suppressor Cells: Major Figures that Shape the Immunosuppressive and Angiogenic Network in Cancer
Eleni-Kyriaki Vetsika et al.
CELLS (2019)
Tumor-associated macrophages: an accomplice in solid tumor progression
Yibing Chen et al.
JOURNAL OF BIOMEDICAL SCIENCE (2019)
A Review of Controlled Drug Delivery Systems Based on Cells and Cell Membranes
Seyed Mohammad Zargar et al.
JOURNAL OF MEDICAL SIGNALS & SENSORS (2019)
Cell Type-Specific Roles of NF-κB Linking Inflammation and Thrombosis
Marion Mussbacher et al.
FRONTIERS IN IMMUNOLOGY (2019)
Remodeling the Microenvironment before Occurrence and Metastasis of Cancer
Xina Zhang et al.
INTERNATIONAL JOURNAL OF BIOLOGICAL SCIENCES (2019)
Hypoxia-Modified Cancer Cell Metabolism
Wafaa Al Tameemi et al.
FRONTIERS IN CELL AND DEVELOPMENTAL BIOLOGY (2019)
Highlighted STAT3 as a potential drug target for cancer therapy
Haeri Lee et al.
BMB REPORTS (2019)
Cellular Interactions in the Tumor Microenvironment: The Role of Secretome
Bianca Rodrigues da Cunha et al.
JOURNAL OF CANCER (2019)
Nanoparticle orientation to control RNA loading and ligand display on extracellular vesicles for cancer regression
Fengmei Pi et al.
NATURE NANOTECHNOLOGY (2018)
The clinical relevance of serum vascular endothelial growth factor (VEGF) in correlation to circulating tumor cells and other serum biomarkers in patients with metastatic breast cancer
Malgorzata Banys-Paluchowski et al.
BREAST CANCER RESEARCH AND TREATMENT (2018)
The breast tumor microenvironment: role in cancer development, progression and response to therapy
Suruchi Mittal et al.
EXPERT REVIEW OF MOLECULAR DIAGNOSTICS (2018)
Clinical significance of interleukin-6 in diagnosis of lung, oral, esophageal, and gall bladder carcinomas
Anjali Vinocha et al.
JOURNAL OF CANCER RESEARCH AND THERAPEUTICS (2018)
The biology and role of CD44 in cancer progression: therapeutic implications
Chen Chen et al.
JOURNAL OF HEMATOLOGY & ONCOLOGY (2018)
Targeting the IL-6/JAK/STAT3 signalling axis in cancer
Daniel E. Johnson et al.
NATURE REVIEWS CLINICAL ONCOLOGY (2018)
Noncoding RNAs: Master Regulators of Inflammatory Signaling
Chen Li Chew et al.
TRENDS IN MOLECULAR MEDICINE (2018)
Tumor-associated macrophage-derived cytokines enhance cancer stem-like characteristics through epithelial-mesenchymal transition
Yongxu Chen et al.
ONCOTARGETS AND THERAPY (2018)
Current Trends and Challenges in the Clinical Translation of Nanoparticulate Nanomedicines: Pathways for Translational Development and Commercialization
Susan Hua et al.
FRONTIERS IN PHARMACOLOGY (2018)
The Regulation of Inflammation by Innate and Adaptive Lymphocytes
David Alex Cronkite et al.
JOURNAL OF IMMUNOLOGY RESEARCH (2018)
Tumor Angiogenesis: A Key Target for Cancer Therapy
Dieter Marme
ONCOLOGY RESEARCH AND TREATMENT (2018)
Plasma inflammatory cytokines and survival of pancreatic cancer patients
A. Babic et al.
CLINICAL AND TRANSLATIONAL GASTROENTEROLOGY (2018)
Immunological Approaches Towards Cancer and Inflammation: A Cross Talk
Xinglong Qu et al.
FRONTIERS IN IMMUNOLOGY (2018)
Leukocyte-derived biomimetic nanoparticulate drug delivery systems for cancer therapy
Yukun Huang et al.
ACTA PHARMACEUTICA SINICA B (2018)
Hyaluronic acid-capped compact silica-supported mesoporous titania nanoparticles for ligand-directed delivery of doxorubicin
Biki Gupta et al.
ACTA BIOMATERIALIA (2018)
Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries
Freddie Bray et al.
CA-A CANCER JOURNAL FOR CLINICIANS (2018)
Treg Destabilization and Reprogramming: Implications for Cancer Immunotherapy
David H. Munn et al.
CANCER RESEARCH (2018)
Hsa-miRNA-143-3p Reverses Multidrug Resistance of Triple-Negative Breast Cancer by Inhibiting the Expression of Its Target Protein Cytokine-Induced Apoptosis Inhibitor 1 In Vivo
Yu Wei Deng et al.
JOURNAL OF BREAST CANCER (2018)
Cell-based drug delivery systems for biomedical applications
Teng Li et al.
NANO RESEARCH (2018)
Neutrophil membrane-coated nanoparticles inhibit synovial inflammation and alleviate joint damage in inflammatory arthritis
Qiangzhe Zhang et al.
NATURE NANOTECHNOLOGY (2018)
Concise Review: Mesenchymal Stem Cell-Based Drug Delivery: The Good, the Bad, the Ugly, and the Promise
Timothy E. G. Krueger et al.
STEM CELLS TRANSLATIONAL MEDICINE (2018)
Current aspects in treatment of breast cancer based of nanodrug delivery systems and future prospects
Adil M. Allahverdiyev et al.
ARTIFICIAL CELLS NANOMEDICINE AND BIOTECHNOLOGY (2018)
Half-Chain Cetuximab Nanoconjugates Allow Multitarget Therapy of Triple Negative Breast Cancer
Miriam Colombo et al.
BIOCONJUGATE CHEMISTRY (2018)
The significant role of interleukin-6 and its signaling pathway in the immunopathogenesis and treatment of breast cancer
Ali Masjedi et al.
BIOMEDICINE & PHARMACOTHERAPY (2018)
Prognostic role of myeloid-derived suppressor cells in cancers: a systematic review and meta-analysis
Lisha Ai et al.
BMC CANCER (2018)
Roles of the immune system in cancer: from tumor initiation to metastatic progression
Hugo Gonzalez et al.
GENES & DEVELOPMENT (2018)
Co-Delivery of Gemcitabine and Paclitaxel in cRGD-Modified Long Circulating Nanoparticles with Asymmetric Lipid Layers for Breast Cancer Treatment
Jing Zhang et al.
MOLECULES (2018)
Inflammation and cancer
Mariko Murata
ENVIRONMENTAL HEALTH AND PREVENTIVE MEDICINE (2018)
NF-κB, inflammation, immunity and cancer: coming of age
Koji Taniguchi et al.
NATURE REVIEWS IMMUNOLOGY (2018)
Drug-Carrying Capacity and Anticancer Effect of the Folic Acid-and Berberine-Loaded Silver Nanomaterial To Regulate the AKT-ERK Pathway in Breast Cancer
Ramasamy Bhanumathi et al.
ACS OMEGA (2018)
Underlying Causes and Therapeutic Targeting of the Inflammatory Tumor Microenvironment
Elizabeth A. Comen et al.
FRONTIERS IN CELL AND DEVELOPMENTAL BIOLOGY (2018)
Reactive Oxygen Species: A Key Constituent in Cancer Survival
Seema Kumari et al.
BIOMARKER INSIGHTS (2018)
Therapeutic Small Molecules Target Inhibitor of Apoptosis Proteins in Cancers with Deregulation of Extrinsic and Intrinsic Cell Death Pathways
Adeeb Derakhshan et al.
CLINICAL CANCER RESEARCH (2017)
Triple-negative breast cancer: is there a treatment on the horizon?
Hui Yao et al.
ONCOTARGET (2017)
Advances of blood cell-based drug delivery systems
Yanan Sun et al.
EUROPEAN JOURNAL OF PHARMACEUTICAL SCIENCES (2017)
Tumor-associated macrophages: implications in cancer immunotherapy
Amy J. Petty et al.
IMMUNOTHERAPY (2017)
The Role of Tumor Microenvironment in Chemoresistance: To Survive, Keep Your Enemies Closer
Dimakatso Alice Senthebane et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2017)
Co-delivery of autophagy inhibitor ATG7 siRNA and docetaxel for breast cancer treatment
Chunai Gong et al.
JOURNAL OF CONTROLLED RELEASE (2017)
Inflammatory factor TNF-α promotes the growth of breast cancer via the positive feedback loop of TNFR1/NF-κB (and/or p38)/p-STAT3/HBXIP/TNFR1
Xiaoli Cai et al.
ONCOTARGET (2017)
The tumor microenvironment and inflammatory breast cancer
Aji Huang et al.
JOURNAL OF CANCER (2017)
Exploring the Role of RGD-Recognizing Integrins in Cancer
Markus Nieberler et al.
CANCERS (2017)
NF-kappaB Is Involved in the Regulation of EMT Genes in Breast Cancer Cells
Bruno R. B. Pires et al.
PLOS ONE (2017)
Study of the tumor microenvironment during breast cancer progression
Rahil Eftekhari et al.
CANCER CELL INTERNATIONAL (2017)
NF-kappa B signaling in inflammation
Ting Liu et al.
SIGNAL TRANSDUCTION AND TARGETED THERAPY (2017)
Concurrently suppressing multidrug resistance and metastasis of breast cancer by co-delivery of paclitaxel and honokiol with pH-sensitive polymeric micelles
Ziqi Wang et al.
ACTA BIOMATERIALIA (2017)
Interleukin-6/STAT3 signaling as a promising target to improve the efficacy of cancer immunotherapy
Hidemitsu Kitamura et al.
CANCER SCIENCE (2017)
Chemokines in the cancer microenvironment and their relevance in cancer immunotherapy
Nisha Nagarsheth et al.
NATURE REVIEWS IMMUNOLOGY (2017)
Role of tumor microenvironment in triple-negative breast cancer and its prognostic significance
Tianjian Yu et al.
CHINESE JOURNAL OF CANCER RESEARCH (2017)
Overcoming chemotherapy drug resistance by targeting inhibitors of apoptosis proteins (IAPs)
Rama Rathore et al.
APOPTOSIS (2017)
DR5 suppression induces sphingosine-1-phosphate-dependent TRAF2 polyubiquitination, leading to activation of JNK/AP-1 and promotion of cancer cell invasion
You-Take Oh et al.
CELL COMMUNICATION AND SIGNALING (2017)
Clinical Practice Guidelines on the Evidence-Based Use of Integrative Therapies During and After Breast Cancer Treatment
Heather Greenlee et al.
CA-A CANCER JOURNAL FOR CLINICIANS (2017)
Tumor microenvironment and therapeutic response
Ting Wu et al.
CANCER LETTERS (2017)
Dual role of inflammatory mediators in cancer
T. G. Shrihari
ECANCERMEDICALSCIENCE (2017)
An overview of the role of neutrophils in innate immunity, inflammation and host-biomaterial integration
Gretchen S. Selders et al.
REGENERATIVE BIOMATERIALS (2017)
Nanoparticles Coated with Neutrophil Membranes Can Effectively Treat Cancer Metastasis
Ting Kang et al.
ACS NANO (2017)
Dual pH-sensitive micelles with charge-switch for controlling cellular uptake and drug release to treat metastatic breast cancer
Shan Tang et al.
BIOMATERIALS (2017)
M-CSF and GM-CSF Receptor Signaling Differentially Regulate Monocyte Maturation and Macrophage Polarization in the Tumor Microenvironment
Eva Van Overmeire et al.
CANCER RESEARCH (2016)
Constitutive activation of STAT3 in breast cancer cells: A review
Kasturi Banerjee et al.
INTERNATIONAL JOURNAL OF CANCER (2016)
Induction of miRNA-181a by genotoxic treatments promotes chemotherapeutic resistance and metastasis in breast cancer
J. Niu et al.
ONCOGENE (2016)
Liposomes Coated with Isolated Macrophage Membrane Can Target Lung Metastasis of Breast Cancer
Haiqiang Cao et al.
ACS NANO (2016)
Signal transducer and activator of transcription 3 as a therapeutic target for cancer and the tumor microenvironment
Byung-Hak Kim et al.
ARCHIVES OF PHARMACAL RESEARCH (2016)
Mechanisms and biomaterials in pH-responsive tumour targeted drug delivery: A review
Manju Kanamala et al.
BIOMATERIALS (2016)
Mammalian drug efflux transporters of the ATP binding cassette (ABC) family in multidrug resistance: A review of the past decade
Zhaolin Chen et al.
CANCER LETTERS (2016)
TRAF2 exerts opposing effects on basal and TNFα-induced activation of the classic IKK complex in hematopoietic cells in mice
Laiqun Zhang et al.
JOURNAL OF CELL SCIENCE (2016)
111In-labeled trastuzumab-modified gold nanoparticles are cytotoxic in vitro to HER2-positive breast cancer cells and arrest tumor growth in vivo in athymic mice after intratumoral injection
Zhongli Cai et al.
NUCLEAR MEDICINE AND BIOLOGY (2016)
SFRP2 augments WNT16B signaling to promote therapeutic resistance in the damaged tumor microenvironment
Y. Sun et al.
ONCOGENE (2016)
Downregulation of human intercellular adhesion molecule-1 attenuates the metastatic ability in human breast cancer cell lines
Dalin Di et al.
ONCOLOGY REPORTS (2016)
Recommendations for myeloid-derived suppressor cell nomenclature and characterization standards
Vincenzo Bronte et al.
NATURE COMMUNICATIONS (2016)
Potential therapeutic implications of IL-6/IL-6R/gp130-targeting agents in breast cancer
Tae-Hwe Heo et al.
ONCOTARGET (2016)
Hypoxia-responsive drug-drug conjugated nanoparticles for breast cancer synergistic therapy
Ruilong Zhang et al.
RSC ADVANCES (2016)
Cytokine patterns in cancer patients: A review of the correlation between interleukin 6 and prognosis
Bodo E. Lippitz et al.
ONCOIMMUNOLOGY (2016)
Roles of NF-κB in Cancer and Inflammatory Diseases and Their Therapeutic Approaches
Mi Hee Park et al.
CELLS (2016)
Stromal Myofibroblasts Are Associated with Poor Prognosis in Solid Cancers: A Meta-Analysis of Published Studies
Liu Liu et al.
PLOS ONE (2016)
Tumor-associated macrophages: unwitting accomplices in breast cancer malignancy
Carly Bess Williams et al.
NPJ BREAST CANCER (2016)
Emerging role of microRNA-21 in cancer
Yin-Hsun Feng et al.
BIOMEDICAL REPORTS (2016)
The biology and function of fibroblasts in cancer
Raghu Kalluri
NATURE REVIEWS CANCER (2016)
Tumor-associated stromal cells as key contributors to the tumor microenvironment
Karen M. Bussard et al.
BREAST CANCER RESEARCH (2016)
RGD peptide-modified multifunctional dendrimer platform for drug encapsulation and targeted inhibition of cancer cells
Xuedan He et al.
COLLOIDS AND SURFACES B-BIOINTERFACES (2015)
The Role of Cytokines in Breast Cancer Development and Progression
Marcela Esquivel-Velazquez et al.
JOURNAL OF INTERFERON AND CYTOKINE RESEARCH (2015)
Principles of nanoparticle design for overcoming biological barriers to drug delivery
Elvin Blanco et al.
NATURE BIOTECHNOLOGY (2015)
Role of the Tumor Microenvironment in Breast Cancer
Savas D. Soysal et al.
PATHOBIOLOGY (2015)
The Role of the Mediators of Inflammation in Cancer Development
Jose Verissimo Fernandes et al.
PATHOLOGY & ONCOLOGY RESEARCH (2015)
Tumor-extracellular matrix interactions: Identification of tools associated with breast cancer progression
Marta Giussani et al.
SEMINARS IN CANCER BIOLOGY (2015)
Inflammation and cancer: Till death tears them apart
T. P. Raposo et al.
VETERINARY JOURNAL (2015)
Targeted nanoparticles for image-guided treatment of triple-negative breast cancer: clinical significance and technological advances
Jasmine M. Miller-Kleinhenz et al.
WILEY INTERDISCIPLINARY REVIEWS-NANOMEDICINE AND NANOBIOTECHNOLOGY (2015)
Signal Transduction in Cancer
Richard Sever et al.
COLD SPRING HARBOR PERSPECTIVES IN MEDICINE (2015)
Cancer metastases: challenges and opportunities
Xiangming Guan
ACTA PHARMACEUTICA SINICA B (2015)
SOCS3-mediated regulation of inflammatory cytokines in PTEN and p53 inactivated triple negative breast cancer model
G. Kim et al.
ONCOGENE (2015)
Expression of truncated human epidermal growth factor receptor 2 on circulating tumor cells of breast cancer patients
Galatea Kallergi et al.
BREAST CANCER RESEARCH (2015)
Tumor-induced perturbations of cytokines and immune cell networks
Brett Burkholder et al.
BIOCHIMICA ET BIOPHYSICA ACTA-REVIEWS ON CANCER (2014)
Inflammation Amplifier, a New Paradigm in Cancer Biology
Toru Atsumi et al.
CANCER RESEARCH (2014)
Ligand-mediated active targeting for enhanced oral absorption
Xingwang Zhang et al.
DRUG DISCOVERY TODAY (2014)
The CXCL8/IL-8 chemokine family and its receptors in inflammatory diseases
Remo C. Russo et al.
EXPERT REVIEW OF CLINICAL IMMUNOLOGY (2014)
STAT3 Induction of miR-146b Forms a Feedback Loop to Inhibit the NF-κB to IL-6 Signaling Axis and STAT3-Driven Cancer Phenotypes
Michael Xiang et al.
SCIENCE SIGNALING (2014)
NF-κB, an Active Player in Human Cancers
Yifeng Xia et al.
CANCER IMMUNOLOGY RESEARCH (2014)
Structural basis for molecular recognition of folic acid by folate receptors
Chen Chen et al.
NATURE (2013)
NF-κB and STAT3 signaling pathways collaboratively link inflammation to cancer
Yihui Fan et al.
PROTEIN & CELL (2013)
Targeting nuclear factor-kappa B to overcome resistance to chemotherapy
P. Godwin et al.
FRONTIERS IN ONCOLOGY (2013)
Lipid-Based Nanovectors for Targeting of CD44-Overexpressing Tumor Cells
Silvia Arpicco et al.
JOURNAL OF DRUG DELIVERY (2013)
The tumor microenvironment is a dominant force in multidrug resistance
Ana Luisa Correia et al.
DRUG RESISTANCE UPDATES (2012)
The seed and soil hypothesis revisited-The role of tumor-stroma interactions in metastasis to different organs
Robert R. Langley et al.
INTERNATIONAL JOURNAL OF CANCER (2011)
In vivo labeling with 2H2O reveals a human neutrophil lifespan of 5.4 days
Janesh Pillay et al.
BLOOD (2010)
Polarization of Tumor-Associated Neutrophil Phenotype by TGF-β: N1 versus N2 TAN
Zvi G. Fridlender et al.
CANCER CELL (2009)
Myeloid-derived suppressor cells as regulators of the immune system
Dmitry I. Gabrilovich et al.
NATURE REVIEWS IMMUNOLOGY (2009)
Aromatase inhibitors in the treatment of breast cancer
RW Brueggemeier et al.
ENDOCRINE REVIEWS (2005)
Tumorigenesis and the angiogenic switch
G Bergers et al.
NATURE REVIEWS CANCER (2003)
Activity of interleukin 6 in the differentiation of monocytes to macrophages and dendritic cells
H Mitani et al.
BRITISH JOURNAL OF HAEMATOLOGY (2000)
分享论文
